COHANCE Cohance Lifesciences Ltd. — Smart-Money Activity, F&O Buildup & Bulk Deals
Sector: HealthcareSmart Money Verdict synthesis of derivatives, deals, and promoter files
Analysis what the data is telling us about COHANCE
Cohance Lifesciences Ltd. did not have meaningful F&O activity in the last completed session. That doesn't mean the stock is irrelevant — it just means the smart-money signals here come from cash markets and corporate disclosures, covered below.
There have been no notable bulk or block deals from FIIs, mutual funds, or insurance companies in Cohance Lifesciences Ltd. over the last 30 sessions.
Putting it together, the smart-money picture for Cohance Lifesciences Ltd. is balanced between accumulation and distribution forces.
F&O Positioning EOD derivatives setup
Quote Details key metrics & weights
Technical Snapshot from 400 sessions of price history
Key Fundamentals headline ratios · Healthcare
Fundamental ratios sourced from public market data, refreshed periodically; verify against company filings before relying on them.
Institutional Deals last 30 sessions (bulk & block)
Broker Calls as reported · last 120 days
| Date | Brokerage | Call | Target | Source |
|---|---|---|---|---|
| 2026-07-21 | Jefferies | Target cut | — | The Economic Times |
| 2026-07-20 | Jefferies | Target cut | — | The Economic Times |
| 2026-07-19 | Jefferies | Target cut | — | The Economic Times |
| 2026-07-18 | Jefferies | Target cut | — | The Economic Times |
| 2026-07-17 | Jefferies | Target cut | — | The Economic Times |
| 2026-07-16 | Jefferies | Target cut | — | The Economic Times |
| 2026-07-15 | Jefferies | Target cut | — | The Economic Times |
| 2026-07-14 | Jefferies | Target cut | — | The Economic Times |
| 2026-07-13 | Jefferies | Target cut | — | The Economic Times |
Insider & Promoter Filings last 60 days
Latest News recent coverage from Reuters, Simply Wall St, MT Newswires and others
COHANCE — frequently asked questions
What is the Cohance Lifesciences Ltd. share price today?
COHANCE is trading at ₹445.65 (-1.12% vs previous close), per the latest update on this page.
What is the P/E ratio of Cohance Lifesciences Ltd.?
COHANCE (Cohance Lifesciences Ltd.) has a trailing twelve-month P/E ratio of 95.0.
What is the market cap of Cohance Lifesciences Ltd.?
COHANCE has a market capitalisation of approximately ₹17,065 crore.
What is the ROE of Cohance Lifesciences Ltd.?
COHANCE has a return on equity (ROE) of about 3.8%.
Is COHANCE near its 52-week high?
COHANCE is trading -60.2% from its 52-week high of ₹1,121.15 as of 2026-07-21.
What is the RSI of COHANCE?
The 14-day RSI of COHANCE is 52.3, which is considered neutral.
Is COHANCE above its 200-day moving average?
COHANCE is trading below its 200-DMA of ₹482.47 (-7.6% away).
Are FIIs or big investors buying COHANCE?
Strota tracks every bulk and block deal in COHANCE with named buyers and sellers, plus promoter and insider filings — the tables on this page list the most recent institutional activity as disclosed to the exchanges.
What is the latest broker call on COHANCE?
The most recent analyst call reported in the press is Jefferies: Target cut (2026-07-21). The Broker Calls section on this page lists reported calls from the last 120 days with links to the original reports.